Antidepressant Drugmaker Seaport Seeks $212.4 Million in US IPO

Seaport, an antidepressant drugmaker, is seeking $212.4 million through a U.S. initial public offering (IPO). The company aims to raise capital as part of its expansion plans in the pharmaceutical sector.